Need professional-grade analysis? Visit stockanalysis.com
$1.13T
14.52
2,253
0.58%
Chong Kun Dang Pharmaceutical (185750) trades on KO in KRW. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at KRW85700.00, down 3.92% from the previous close.
Over the past year, 185750 has traded between a low of KRW78700.00 and a high of KRW97700.00. The stock has gained 8.6% over this period. It is currently 12.3% below its 52-week high.
Chong Kun Dang Pharmaceutical has a market capitalization of $1.13T, with a price-to-earnings ratio of 14.52 and a dividend yield of 0.58%.
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Side-by-side comparison against top Healthcare peers.